Growth of Bioartificial Tissue Containing an Inbuilt Blood Supply. The large and growing demand for replacement tissues and organs has spurred rapid growth in the emerging field of tissue engineering, which aims to form new tissues in the laboratory by combining living cells and synthetic scaffolds. A major challenge lies in the production of thick tissues, which require a blood supply in order to survive. Uniquely, this project aims to grow in the laboratory a vascular system based on natural ....Growth of Bioartificial Tissue Containing an Inbuilt Blood Supply. The large and growing demand for replacement tissues and organs has spurred rapid growth in the emerging field of tissue engineering, which aims to form new tissues in the laboratory by combining living cells and synthetic scaffolds. A major challenge lies in the production of thick tissues, which require a blood supply in order to survive. Uniquely, this project aims to grow in the laboratory a vascular system based on natural structures, which can then be used to support new tissue growth. Australia is well placed to reap the rewards of this work, having a track record in commercialisation of medical technologies, resulting in an improved quality of life for many Australians and substantial direct and indirect economic benefits.Read moreRead less
Scaffolds for bone tissue regeneration and use in orthopaedic applications. Damaged joints do not repair spontaneously, often leading to arthritis. Bone defects resulting from congenital defects or disease processes are challenging to regenerate and represent a major financial burden to our health system. Bone graft treatments are widely used but have considerable drawbacks. This created a need for scaffolds to provide temporary support for new bone. However they lack the combined physical/biolo ....Scaffolds for bone tissue regeneration and use in orthopaedic applications. Damaged joints do not repair spontaneously, often leading to arthritis. Bone defects resulting from congenital defects or disease processes are challenging to regenerate and represent a major financial burden to our health system. Bone graft treatments are widely used but have considerable drawbacks. This created a need for scaffolds to provide temporary support for new bone. However they lack the combined physical/biological properties necessary for bone repair. We developed new scaffolds with improved mechanical/biological properties to mimic bone which will lead to new treatments for bone damage.Read moreRead less
Novel Drug Delivery Systems. The polymer based structures targeted for production in this project will bring unique capabilities to the field of drug delivery. A multi-drug delivery platform is expected to bring significant improvements in administering therapeutic drugs for a wide range of illnesses and applications. This will have profound effects on the quality of life for those suffering from epilepsy or requiring stent implants. Here we will demonstrate the capabilities of these novel polym ....Novel Drug Delivery Systems. The polymer based structures targeted for production in this project will bring unique capabilities to the field of drug delivery. A multi-drug delivery platform is expected to bring significant improvements in administering therapeutic drugs for a wide range of illnesses and applications. This will have profound effects on the quality of life for those suffering from epilepsy or requiring stent implants. Here we will demonstrate the capabilities of these novel polymer structures both in-vitro and in-vivo.Read moreRead less
Development and characterisation of novel hydrogel systems for drug delivery. The aims of this project are to develop and characterise hydrogel formulations for delivery of active agents, such as protein drugs, and to examine the biological responses to drug loaded hydrogels. In many medical and industrial fields, it is advantageous to control the release of active agents. Controlled release can decrease the dose of active that must be administered, sustain a more constant level of the agent ....Development and characterisation of novel hydrogel systems for drug delivery. The aims of this project are to develop and characterise hydrogel formulations for delivery of active agents, such as protein drugs, and to examine the biological responses to drug loaded hydrogels. In many medical and industrial fields, it is advantageous to control the release of active agents. Controlled release can decrease the dose of active that must be administered, sustain a more constant level of the agent in the environment and can localise the agent at the site where it is needed. This project will advance the theoretical knowledge of polymer degradation combined with protein release, will develop controlled release hydrogel technology that can be applied to medical devices and will train a postgraduate student in biomaterials and drug delivery.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0668541
Funder
Australian Research Council
Funding Amount
$260,000.00
Summary
Infrastructure for design and testing of implantable and non-invasive intelligent medical devices. This application requests infrastructure funding to ensure the capability of the UTS and UNSW biomedical engineering teams to develop tomorrow's biomedical devices. It will enable research in the field of intelligent medical devices, either non-invasive devices (diabetes monitoring, brain-computer interfaces, home telecare) or those which are fully implanted (heart pumps, bionic eyes). Such biomedi ....Infrastructure for design and testing of implantable and non-invasive intelligent medical devices. This application requests infrastructure funding to ensure the capability of the UTS and UNSW biomedical engineering teams to develop tomorrow's biomedical devices. It will enable research in the field of intelligent medical devices, either non-invasive devices (diabetes monitoring, brain-computer interfaces, home telecare) or those which are fully implanted (heart pumps, bionic eyes). Such biomedical devices will save lives and improve the quality of life of many people. The commercial benefit to Australia flows from the international export of such devices. Based on this approach there will be substantial savings in health care costs, with patients able to resume a better quality of life at home, rather than in institutional care.Read moreRead less
Design of an electronic guideline-driven decision support framework for home and community telehealth settings. With rapid advancements in the use of telecare-based health support in several emerging clinical areas, integrating these services within a stable guideline-driven decision support framework will support evidence-best practice in this setting, as well as improving efficiencies in clinical work practice and error minimisation through automation. The result could have a profound socio-ec ....Design of an electronic guideline-driven decision support framework for home and community telehealth settings. With rapid advancements in the use of telecare-based health support in several emerging clinical areas, integrating these services within a stable guideline-driven decision support framework will support evidence-best practice in this setting, as well as improving efficiencies in clinical work practice and error minimisation through automation. The result could have a profound socio-economic impact on the community and a sizable impact on healthcare outcomes; notwithstanding the substantial contribution it has to advancing the knowledge of medical decision support systems, supporting the national technology focus on health technology interoperability, and raising the profile of Australia as the foremost leader in the telecare area. Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0668506
Funder
Australian Research Council
Funding Amount
$150,000.00
Summary
A Multi-Axis Biomaterials Testing Facility. Damage to bones and joints, due to injury or diseases such as osteoporosis and arthritis, is a major cause of disability and cost to the nation. Australia's ageing population contributes not only to an increasing incidence of such conditions, but also to more patients out-living implants such as replacement joints. In 2001-2, Australia spent over $800 million on joint replacement. Because over 11% of procedures are revisions of failed implants, even sm ....A Multi-Axis Biomaterials Testing Facility. Damage to bones and joints, due to injury or diseases such as osteoporosis and arthritis, is a major cause of disability and cost to the nation. Australia's ageing population contributes not only to an increasing incidence of such conditions, but also to more patients out-living implants such as replacement joints. In 2001-2, Australia spent over $800 million on joint replacement. Because over 11% of procedures are revisions of failed implants, even small improvements in implant life represent significant cost savings. By accurately simulating conditions within the body, this biomechanical testing facility will lead to new developments in implant designs and materials, in turn improving quality of life, productivity and treatment costs.Read moreRead less
Special Research Initiatives - Grant ID: SR0354734
Funder
Australian Research Council
Funding Amount
$10,000.00
Summary
The Australian Research Network for Medical Devices: advanced technology solutions for patients and practitioners. Medical Device technologies embrace a wide range of scientific, engineering and medical knowledge, with the goal of assisting a clinical professional (doctor or nurse) deliver a service to a patient in an efficacious, cost effective manner. Development of appropriate medical devices, whether for diagnosis, treatment or prevention of disease or disability, is critical to improving h ....The Australian Research Network for Medical Devices: advanced technology solutions for patients and practitioners. Medical Device technologies embrace a wide range of scientific, engineering and medical knowledge, with the goal of assisting a clinical professional (doctor or nurse) deliver a service to a patient in an efficacious, cost effective manner. Development of appropriate medical devices, whether for diagnosis, treatment or prevention of disease or disability, is critical to improving health care and reducing health care costs. To be successful, a device must include all relevant disciplines in the research, development and testing phases. This network will bring together these groups, promoting knowledge sharing and cross-disciplinary investigations that illuminate current device limitations and potential solutions.Read moreRead less
Interfacial interactions with hydrogel biomaterials. The interactions between cells of the body and the surfaces of medical implants are controlled largely by the molecules that are adsorbed on the surface. The aim of this project is to evaluate the effect of modifying hydrogel biomaterials on the interactions of the molecules with the hydrogel. This, in turn, allows us to determine the factors affecting the control of the cell's response. The significance of this work is in the improved ability ....Interfacial interactions with hydrogel biomaterials. The interactions between cells of the body and the surfaces of medical implants are controlled largely by the molecules that are adsorbed on the surface. The aim of this project is to evaluate the effect of modifying hydrogel biomaterials on the interactions of the molecules with the hydrogel. This, in turn, allows us to determine the factors affecting the control of the cell's response. The significance of this work is in the improved ability to control cellular responses to implants. Such improved response will result in better health outcomes for patients, and outcomes in the form of papers and intellectual property.
Read moreRead less
Engineering the convergence of telecare and telehealth. This project will design a wrist-worn pendant that represents the convergence of telecare (fall detection and personal alarm pendants) and telehealth (remote management of chronic disease). The system has the potential to be retro-fitted to 100,000s of telecare systems deployed by an industry partner and to herald a new form of low-cost patient monitoring.